162 related articles for article (PubMed ID: 15960272)
21. Serum cystatin c is not superior to serum creatinine for early diagnosis of contrast-induced nephropathy in patients who underwent angiography.
Xu Q; Wang NN; Duan SB; Liu N; Lei R; Cheng W; Zhou SK
J Clin Lab Anal; 2017 Sep; 31(5):. PubMed ID: 27897324
[TBL] [Abstract][Full Text] [Related]
22. Contrast-induced nephropathy in patients undergoing emergency percutaneous coronary intervention for acute coronary syndrome.
Senoo T; Motohiro M; Kamihata H; Yamamoto S; Isono T; Manabe K; Sakuma T; Yoshida S; Sutani Y; Iwasaka T
Am J Cardiol; 2010 Mar; 105(5):624-8. PubMed ID: 20185007
[TBL] [Abstract][Full Text] [Related]
23. [Clinical impact of nephropathy induced by contrast medium in patients with acute myocardial infarction undergoing emergent coronary angiography].
Jujo K; Yamaguchi J; Obayashi K; Suzuki K; Sekiguchi H; Nagashima M; Tsurumi Y; Kasanuki H
J Cardiol; 2006 Jul; 48(1):9-16. PubMed ID: 16886495
[TBL] [Abstract][Full Text] [Related]
24. [Contrast-induced nephropathy in coronarography of patients with type 2 diabetes mellitus: risk factors, prognostic significance, prophylactic approaches].
Shamkhalova MSh; Zaĭtseva NV; Kurumova KO; Shestakova MV; Deev AD; Matskeplishvili ST; Tugeeva EF; Buziashvili IuI
Ter Arkh; 2009; 81(8):36-42. PubMed ID: 19799198
[TBL] [Abstract][Full Text] [Related]
25. Trimetazidine Prevention of Contrast-Induced Nephropathy in Coronary Angiography.
Liu W; Ming Q; Shen J; Wei Y; Li W; Chen W; Xu Y
Am J Med Sci; 2015 Nov; 350(5):398-402. PubMed ID: 26445302
[TBL] [Abstract][Full Text] [Related]
26. Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography.
Oldemeyer JB; Biddle WP; Wurdeman RL; Mooss AN; Cichowski E; Hilleman DE
Am Heart J; 2003 Dec; 146(6):E23. PubMed ID: 14661012
[TBL] [Abstract][Full Text] [Related]
27. [Risk factors of contrast-induced nephropathy in patients after coronary artery intervention].
Zhao YY; Liu DW; Wang JS; Ouyang J; Zhang WZ; Zhang WJ; Meng JQ; Tang JM
Zhonghua Yi Xue Za Zhi; 2012 Jun; 92(22):1547-9. PubMed ID: 22944059
[TBL] [Abstract][Full Text] [Related]
28. Prediction of contrast-induced nephropathy in diabetics undergoing elective percutaneous coronary intervention: role of the ratio of contrast medium volume to estimated glomerular filtration rate.
Wang XC; Fu XH; Wang YB; Jia XW; Wu WL; Gu XS; Zhang J; Su JL; Hao GZ; Jiang YF; Fan WZ; Li SQ
Chin Med J (Engl); 2011 Mar; 124(6):892-6. PubMed ID: 21518598
[TBL] [Abstract][Full Text] [Related]
29. Contrast-induced nephropathy and risk of acute kidney injury and mortality after cardiac operations.
Garcia S; Ko B; Adabag S
Ann Thorac Surg; 2012 Sep; 94(3):772-6. PubMed ID: 22835553
[TBL] [Abstract][Full Text] [Related]
30. Contrast-medium-Induced nephropathy correlated to the ratio between dose in gram iodine and estimated GFR in ml/min.
Nyman U; Almén T; Aspelin P; Hellström M; Kristiansson M; Sterner G
Acta Radiol; 2005 Dec; 46(8):830-42. PubMed ID: 16392608
[TBL] [Abstract][Full Text] [Related]
31. Does angiography increase the risk of impairment in renal function during non-operative management of patients with blunt splenic injuries? A cross-sectional study in southern Taiwan.
Hsieh TM; Tsai TH; Lin CC; Hsieh CH
BMJ Open; 2016 Oct; 6(10):e012205. PubMed ID: 27798008
[TBL] [Abstract][Full Text] [Related]
32. Contrast-induced nephrotoxicity in renal allograft recipients.
Ahuja TS; Niaz N; Agraharkar M
Clin Nephrol; 2000 Jul; 54(1):11-4. PubMed ID: 10939751
[TBL] [Abstract][Full Text] [Related]
33. The lack of benefit of a combination of an angiotensin receptor blocker and calcium channel blocker on contrast-induced nephropathy in patients with chronic kidney disease.
Oguzhan N; Cilan H; Sipahioglu M; Unal A; Kocyigit I; Kavuncuoglu F; Arikan T; Akpek M; Elcik D; Sahin O; Gulme E; Pala C; Tokgoz B; Utas C; Oguzhan A; Oymak O
Ren Fail; 2013; 35(4):434-9. PubMed ID: 23413781
[TBL] [Abstract][Full Text] [Related]
34. Hyperuricemia as a risk factor for contrast-induced nephropathy in patients with chronic kidney disease.
Toprak O; Cirit M; Esi E; Postaci N; Yesil M; Bayata S
Catheter Cardiovasc Interv; 2006 Feb; 67(2):227-35. PubMed ID: 16400673
[TBL] [Abstract][Full Text] [Related]
35. Iso-osmolar radio contrast iodixanol in patients with chronic kidney disease.
Tadros GM; Malik JA; Manske CL; Kasiske BL; Dickinson SE; Herzog CA; Wilson RF; Das G; Panetta CJ
J Invasive Cardiol; 2005 Apr; 17(4):211-5. PubMed ID: 15831975
[TBL] [Abstract][Full Text] [Related]
36. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial.
Jo SH; Youn TJ; Koo BK; Park JS; Kang HJ; Cho YS; Chung WY; Joo GW; Chae IH; Choi DJ; Oh BH; Lee MM; Park YB; Kim HS
J Am Coll Cardiol; 2006 Sep; 48(5):924-30. PubMed ID: 16949481
[TBL] [Abstract][Full Text] [Related]
37. Renal effects of contrast media in diabetic patients undergoing diagnostic or interventional coronary angiography.
Hardiek KJ; Katholi RE; Robbs RS; Katholi CE
J Diabetes Complications; 2008; 22(3):171-7. PubMed ID: 18413220
[TBL] [Abstract][Full Text] [Related]
38. Risk of nephropathy after consumption of nonionic contrast media by children undergoing cardiac angiography: a prospective study.
Ajami G; Derakhshan A; Amoozgar H; Mohamadi M; Borzouee M; Basiratnia M; Abtahi S; Cheriki S; Soltani M
Pediatr Cardiol; 2010 Jul; 31(5):668-73. PubMed ID: 20195852
[TBL] [Abstract][Full Text] [Related]
39. Effect of theophylline on contrast material-nephropathy in patients with chronic renal insufficiency: controlled, randomized, double-blinded study.
Huber W; Ilgmann K; Page M; Hennig M; Schweigart U; Jeschke B; Lutilsky L; Weiss W; Salmhofer H; Classen M
Radiology; 2002 Jun; 223(3):772-9. PubMed ID: 12034949
[TBL] [Abstract][Full Text] [Related]
40. Use of iso-osmolar nonionic dimeric contrast media in multidetector row computed tomography angiography for patients with renal impairment.
Becker CR; Reiser MF
Invest Radiol; 2005 Oct; 40(10):672-5. PubMed ID: 16189436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]